{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T06:34:30Z","timestamp":1793169270480,"version":"4.5.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"37","license":[{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9,11]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Beh\u00e7et\u2019s syndrome (BS) is a heterogeneous systemic vasculitis characterized by chronic inflammation and immune dysregulation. Growth differentiation factor-15 (GDF-15), a member of the transforming growth factor-\u03b2 superfamily, has been implicated in chronic inflammatory and immune stress responses. This study aimed to evaluate serum GDF-15 levels in patients with BS and to investigate their relationship with disease activity and clinical parameters. This cross-sectional study included 49 patients diagnosed with BS according to International Study Group criteria, as well as a control group of 33 healthy individuals. Demographic characteristics, clinical features, laboratory parameters, treatments, and disease activity scores were recorded. Serum GDF-15 levels were measured using a commercial enzyme-linked immunosorbent assay. Statistical analyses were performed to compare groups and to evaluate associations between GDF-15 levels and clinical and laboratory variables. In the unadjusted comparison, serum GDF-15 levels were significantly higher in patients with BS than in controls (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.016). However, GDF-15 levels were not associated with disease activity scores. In multivariable logistic regression adjusting for sex and BMI, GDF-15 was no longer an independent predictor of BS (adjusted\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.53), whereas sex (OR\u2005=\u20055.61,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.006) and BMI (OR\u2005=\u20050.86,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.024) remained independently associated with the group, indicating that the unadjusted GDF-15 difference largely reflects demographic confounding rather than a disease-specific effect. No significant correlations were observed between GDF-15 levels and classical acute-phase reactants. This study underscores the importance of recognizing negative biomarker findings to prevent overinterpretation of biomarker utility. Although serum GDF-15 levels were higher in patients with BS in the unadjusted comparison, this difference was no longer statistically significant after adjustment for sex and BMI. GDF-15 levels were also not associated with disease activity, limiting their utility as a disease-specific biomarker. Further longitudinal studies are needed.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000050439","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:08:10Z","timestamp":1789142890000},"page":"e50439","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Serum growth differentiation factor-15 levels in Beh\u00e7et\u2019s syndrome"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7031-4716","authenticated-orcid":false,"given":"Mesude Seda","family":"Aydo\u011fdu","sequence":"first","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Malatya Turgut \u00d6zal University, Malatya, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2048-0721","authenticated-orcid":false,"given":"Zeynep","family":"Kaya","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Istanbul Training and Research Hospital, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3278-7779","authenticated-orcid":false,"given":"Cihat","family":"U\u00e7ar","sequence":"additional","affiliation":[{"name":"Physiology Department, Malatya Turgut Ozal University Faculty of Medicine, Malatya, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5730-2286","authenticated-orcid":false,"given":"Sezgin","family":"Zontul","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Physical Medicine and Rehabilitation, Inonu University Faculty of Medicine, Malatya, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5911-6864","authenticated-orcid":false,"given":"Elif","family":"\u0130nan\u00e7","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Inonu University Faculty of Medicine, Malatya, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8516-9769","authenticated-orcid":false,"given":"Servet","family":"Yolba\u015f","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Inonu University Faculty of Medicine, Malatya, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261028","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.rdc.2023.03.010","article-title":"Beh\u00e7et Syndrome.","volume":"49","author":"Hatemi","year":"2023","journal-title":"Rheum Dis Clin North Am"},{"key":"R2-20261028","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.revmed.2013.12.005","article-title":"Epidemiology of Beh\u00e7et\u2019s disease.","volume":"35","author":"Mahr","year":"2014","journal-title":"Rev Med Interne"},{"key":"R3-20261028","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/art.24423","article-title":"Epidemiology and clinical characteristics of Beh\u00e7et\u2019s disease in the US: a population-based study.","volume":"61","author":"Calamia","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R4-20261028","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1002\/art.24642","article-title":"HLA-B51\/B5 and the risk of Beh\u00e7et\u2019s disease: a systematic review and meta-analysis of case-control genetic association studies.","volume":"61","author":"de Menthon","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R5-20261028","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.1002\/art.37708","article-title":"Identification of a susceptibility locus in STAT4 for Beh\u00e7et\u2019s disease in Han Chinese in a genome-wide association study.","volume":"64","author":"Hou","year":"2012","journal-title":"Arthritis Rheum"},{"key":"R6-20261028","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/ng.2520","article-title":"Genome-wide association analysis identifies new susceptibility loci for Beh\u00e7et\u2019s disease and epistasis between HLA-B*51 and ERAP1.","volume":"45","author":"Kirino","year":"2013","journal-title":"Nat Genet"},{"issue":"4 Suppl 30","key":"R7-20261028","first-page":"S44","article-title":"The role of heat shock proteins in Beh\u00e7et\u2019s disease.","volume":"21","author":"Direskeneli","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"R8-20261028","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s11739-018-2000-1","article-title":"Triggering agents and microbiome as environmental factors on Beh\u00e7et\u2019s syndrome.","volume":"14","author":"Mumcu","year":"2019","journal-title":"Intern Emerg Med"},{"key":"R9-20261028","first-page":"1078","article-title":"Criteria for diagnosis of Beh\u00e7et\u2019s disease. International Study Group for Beh\u00e7et\u2019s disease.","volume":"335","year":"1990","journal-title":"Lancet"},{"key":"R10-20261028","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/art.22410","article-title":"Serum macrophage inhibitory cytokine 1 in rheumatoid arthritis: a potential marker of erosive joint destruction.","volume":"56","author":"Brown","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R11-20261028","doi-asserted-by":"crossref","first-page":"11514","DOI":"10.1073\/pnas.94.21.11514","article-title":"MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily.","volume":"94","author":"Bootcov","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R12-20261028","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0378-1119(97)00485-X","article-title":"Identification of a novel member of the TGF-beta superfamily highly expressed in human placenta.","volume":"203","author":"Lawton","year":"1997","journal-title":"Gene"},{"key":"R13-20261028","doi-asserted-by":"crossref","first-page":"951","DOI":"10.3389\/fimmu.2020.00951","article-title":"Growth\/differentiation factor-15 (GDF-15): from biomarker to novel targetable immune checkpoint.","volume":"11","author":"Wischhusen","year":"2020","journal-title":"Front Immunol"},{"key":"R14-20261028","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3758\/BRM.41.4.1149","article-title":"Statistical power analyses using G* Power 3.1: tests for correlation and regression analyses.","volume":"41","author":"Faul","year":"2009","journal-title":"Behav Res Methods"},{"key":"R15-20261028","first-page":"345","article-title":"Elevated serum interleukin 1 receptors and interleukin 1B in patients with Beh\u00e7et\u2019s disease: correlations with disease activity and severity.","volume":"31","author":"Yosipovitch","year":"1995","journal-title":"Isr J Med Sci"},{"key":"R16-20261028","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3109\/08977194.2011.607137","article-title":"The TGF-\u03b2 superfamily cytokine, MIC-1\/GDF15: a pleotrophic cytokine with roles in inflammation, cancer and metabolism.","volume":"29","author":"Breit","year":"2011","journal-title":"Growth Factors"},{"key":"R17-20261028","doi-asserted-by":"crossref","first-page":"926373","DOI":"10.3389\/fimmu.2022.926373","article-title":"GDF-15: a potential biomarker and therapeutic target in systemic lupus erythematosus.","volume":"13","author":"Xu","year":"2022","journal-title":"Front Immunol"},{"key":"R18-20261028","doi-asserted-by":"crossref","first-page":"e12195","DOI":"10.1002\/pul2.12195","article-title":"The diagnostic and prognostic value of growth differentiation factor-15 in systemic lupus erythematosus-associated pulmonary arterial hypertension.","volume":"13","author":"Qian","year":"2023","journal-title":"Pulm Circ"},{"key":"R19-20261028","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1378\/chest.10-0302","article-title":"Increased expression of growth differentiation factor-15 in systemic sclerosis-associated pulmonary arterial hypertension.","volume":"139","author":"Meadows","year":"2011","journal-title":"Chest"},{"key":"R20-20261028","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1093\/rheumatology\/keab277","article-title":"Growth differentiation factor 15 (GDF-15) as potential cardiovascular risk biomarker in antiphospholipid syndrome.","volume":"61","author":"Tektonidou","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"R21-20261028","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1093\/rheumatology\/keaa721","article-title":"The diagnostic value of GDF-15 for myocardial involvement in idiopathic inflammatory myopathy.","volume":"60","author":"Qiu","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"R22-20261028","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1080\/08820139.2017.1360340","article-title":"Growth differentiation factor-15 (GDF-15) level and relation to clinical manifestations in egyptian systemic sclerosis patients: preliminary data.","volume":"46","author":"Gamal","year":"2017","journal-title":"Immunol Invest"},{"key":"R23-20261028","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.2147\/JIR.S350281","article-title":"Association of growth and differentiation factor 15 in rheumatoid arthritis.","volume":"15","author":"He","year":"2022","journal-title":"J Inflamm Res"},{"key":"R24-20261028","doi-asserted-by":"crossref","first-page":"e13733","DOI":"10.1097\/MD.0000000000013733","article-title":"Increased serum levels of MIC1\/GDF15 correlated with bone erosion in spondyloarthritis: a pilot study.","volume":"97","author":"Song","year":"2018","journal-title":"Medicine (Baltim)"},{"key":"R25-20261028","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1007\/s11845-025-03972-x","article-title":"Importance of potential prothrombotic state markers in Beh\u00e7et\u2019s disease and correlation with vascular ultrasound.","volume":"194","author":"Karadeniz","year":"2025","journal-title":"Ir J Med Sci"},{"key":"R26-20261028","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1111\/ijd.13309","article-title":"Serum GDF-15 level in Beh\u00e7et\u2019s disease: relationships between disease activity and clinical parameters.","volume":"55","author":"Sariyildiz","year":"2016","journal-title":"Int J Dermatol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050439","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T06:01:13Z","timestamp":1793167273000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050439"}},"subtitle":["A cross-sectional study"],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":26,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000050439","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,11]]},"assertion":[{"value":"2026-06-11","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-13","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}